ReviewDrugs & aging2015

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty.

Nigel Arden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.